UMIN ID: UMIN000000532
Registered date:01/12/2006
NPB-01(intravenous immunoglobulin)therapy for patients with pemphigus unresponsive to corticosteroids:Multi-center,Randomized,Double-Blind ,Placebo Control,Parallel Assignment Study to examine dose response and efficacy of NPB-01.(Phase2+3)
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Pemphigus |
Date of first enrollment | 2004/11/01 |
Target sample size | 75 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | 0mg/kg per day for 5 days(placebo) 200mg/kg per day for 5 days 400mg/kg per day for 5 days |
Outcome(s)
Primary Outcome | Days up to protocol-off |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | 1)Patients treated with Plasmapheresis 2)Patients treated with corticosteroids pulse therapy (methylpredonizolone over 0.5g/day) 3)Patients received intravenous immunoglobulin 4) Patients with history of shock for NPB-01 5)Patients with history of Hypersensitivity for NPB-01 6)Patients with IgA deficiency 7)Patients with impaired liver function 8)Patients with impaired renal function 9)Patients with cerebro- or cardiovascular disorders or a history of these disorders 10)Patients with a high risk of thromboembolism |
Related Information
Primary Sponsor | NIHON PHARMACEUTICAL CO.,LTD |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | NIHON PHARMACEUTICAL CO.,LTD |
Secondary ID(s) |
Contact
public contact | |
Name | toshikazu okuno |
Address | 3-8,Dosho-machi 2-chome,chuo-ku,Osaka 541-0045,Japan Japan |
Telephone | |
Affiliation | NIHON PHARMACEUTICAL CO.,LTD Clinical Development Department |
scientific contact | |
Name | Koji Hashimoto |
Address | Shitsukawa,Toon,Ehime 791-0295,Japan Japan |
Telephone | |
Affiliation | Ehime University Hospital Department of Dermatology |